期刊
BRITISH JOURNAL OF CANCER
卷 96, 期 5, 页码 732-737出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6603608
关键词
gestational trophoblastic neoplasia; relapse; chemotherapy
类别
The majority of women requiring chemotherapy for gestational trophoblastic disease (GTN) are cured with their initial chemotherapy treatment. However, a small percentage either become refractory to treatment, or relapse after the completion of treatment. This study investigates the characteristics and outcome of these patients. Patients were identified from the Charing Cross Hospital GTD database. The outcome of these patients with relapsed disease was compared to those with refractory disease. Between 1980 and 2004, 1708 patients were treated with chemotherapy for GTN. Sixty (3.5%) patents relapsed following completion of initial therapy. The overall 5-year survival for patients with relapsed GTN was 93% (95% CI 86 - 100%). The overall survival for patients with low-risk and high-risk disease at presentation, who subsequently relapsed was 100% (n = 35), and 84% ( n 25) ( 95% CI: 66 - 96%: P < 0.05), respectively. Eleven patients were identified who failed to enter remission and had refractory disease. These patients had a worse outcome compared to patients with relapsed disease (5-year survival 43% ( 95% CI: 12 - 73% P < 0.01)). The outcome of patients with relapsed GTN is good. However, patients with primary chemo-refractory disease do poorly and novel therapies are required for this group of patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据